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Clinics and pathology 
Disease 
High-grade B-cell lymphoma 
Note 
The chromosomal translocation t(6;20)(q15;q11.2) 
was detected in the cell line BLUE-1.  
This cell line was established from a bone marrow 
sample obtained from a patient with relapsed high-
grade B-cell lymphoma, initially histologically 
classified as Burkitt lymphoma (Burmeister et al., 
2006).  
The cell line also carries the Burkitt-typical 
t(8;14)(q24;q32) with MYC-IGHJ fusion. Further 
characterization of the t(6;20)(q15;q11.2) led to the
identification of a chimeric BACH2-BCL2L1 fusion 
transcript, showing a fusion of the first non-coding 
BACH2 exon to the coding part of BCL2L1. The 
translocation thus effectively leads to an 
overexpression of BCL2L1. 
Phenotype/cell stem origin 
The BLUE-1 cell line has the following 
immunophenotype: CD2-, cyCD3-, CD5-, CD7-, 
CD10+, CD19+, CD20-, cyCD22+, CD23-, cyIgM-, 
CD56-, CD33-, MPO-7-, CD34-, HLA-DR+, TdT-, 
CD52+. 
Epidemiology 
The cell line BLUE-1 is the only known case. 
Clinics 
The patient from whom the cell line was derived 
showed a very aggressive form of lymphoma. Despite 
intensive immunochemotherapy he relapsed, 
developed meningeal involvement and died 3 months 
after the cell line was established. 
Cytology 
Cytomorphology and immunostaining of the BLUE-1 
cells was compatible with the diagnosis of Burkitt 
lymphoma (Burmeister et al., 2006). 
 
The evolved BLUE-1 karyotype shows one der(6)t(6;20)(q13;q11.2), one +6 and three der(20)t(6;20)(q15;q11.2) (one long der(20) 
and two short der(20)) in addition to the normal chromosome 20 (Burmeister et al., 2011). 
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Cytogenetics 
Cytogenetics morphological 
The inital karyotype of BLUE-1 was the following: 
46,XY,t(6;20)(q13;q11.2),t(8;14)(q24;q32). 





0),+21 (Burmeister et al., 2006). The second +20 was
later classified as third der(20). 
Cytogenetics molecular 
Molecular cytogenetics showed a MYC-IGH 
juxtaposition. The following BAC clones were used: 
WI2-1694H13 (8q24), RP11-815O20 and RP11-
965B13 (IGH-Eµ). The t(6;20)(q15;q11.2) was 
characterized using the BAC clones RP11-21G12, 
RP1-154G14, RP1-45N11, RP1-104D1 (on chr 6) 
and RP3-324O17, RP5-857M17, RP11-243J16 and 
RP1-310O13 (on chr 20). 
Genes involved and 
proteins 
BACH2 (BTB and CNC homology 1, 





Two different transcripts have been described, one 7-
exon 9109 bp transcript and one 9-exon 9215 bp 
transcript. The coding last 4 exons are shared by both
transcripts. Both transcripts encode an 841 aa protein. 




Two major BCL2L1 transcripts have been described: 
one long 2559 bp transcript BCL-XL resulting in the 
translation of a 233 aa protein and one short 2370 bp 
transcript BCL-XS, resulting in the translation of a 
170 aa protein. The shorter transcript is generated by 
alternative splicing at the 3' end of BCL2L1 exon 2. 




The translocation t(6;20)(q15;q11.2) was 
characterized using a sequential BAC clone mapping 
strategy. The BAC clones RP11-243J16 (on chr 20) 
and RP1-104D1 (on chr 6) covered the chromosomal 
breakpoint region. The chromosomal breakpoint was 
not identified but is likely located 5' of the first 
BCL2L1 exon and 3' of the first BACH2 exon. 
Transcript 
RT-PCR showed a chimeric BACH2-BCL2 fusion 
transcript. The first non-coding BACH2 exon was 
fused to the second (partially coding) BCL2L1 exon. 
This led to an overexpression of BCL2L1 (BCL-XL). 
Fusion protein 
Note 
Translation of the BACH2-BCL2L1 transcript 
resulted in a strong overexpression of BCL2L1 as 
detected by immunoblotting. 
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